- Sales of weight-loss drug Wegovy doubled in the first quarter as supply improvedon May 2, 2024 at 9:42 am
- Here's what UBS says to do if Powell is wrong on stagflationon May 2, 2024 at 9:07 am
- Shell kicks off $3.5 billion share buyback programon May 2, 2024 at 6:22 am
- Novo Nordisk lifts guidance on strong demand for weight-loss, diabetes drugson May 2, 2024 at 6:01 am
- Poletti: Qualcomm could prove to be an underrated AI storyon May 1, 2024 at 11:54 pm
- Powell keeps the door open for a July rate cut, and other Fed-meeting takeawayson May 1, 2024 at 10:42 pm
- History suggests campus protests could have economic impact on U.S. collegeson May 1, 2024 at 9:53 pm
- Informatica logs earnings beat following acquisition flirtation with Salesforceon May 1, 2024 at 9:47 pm
- Carvana’s stock rallies on surprise profit for used-car retaileron May 1, 2024 at 9:24 pm
- Exxon-Pioneer deal set to be cleared by FTC — but there’s an unusual twiston May 1, 2024 at 9:24 pm
Click Advertiser ♥